About Linshom
Linshom is a company based in Ellicott City (United States) founded in 2009. Linshom has raised $3.35 million across 9 funding rounds from investors including NIH, HHS and TEDCO. Linshom operates in a competitive market with competitors including Apieron, Eversens, Medipines, Deversify and Spirosure, among others.
- Headquarter Ellicott City, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$3.35 M (USD)
in 9 rounds
-
Latest Funding Round
$400 K (USD), Series A
Feb 29, 2024
-
Investors
NIH
& 5 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Linshom
Unlock access to complete
Unlock access to complete
Unlock access to complete
Funding Insights of Linshom
Linshom has successfully raised a total of $3.35M across 9 strategic funding rounds. The most recent funding activity was a Series A round of $400 thousand completed in February 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Linshom
Linshom has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include NIH, HHS and TEDCO.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital fund and startup accelerator programs focused on seed and early stage companies
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
Investment funding is provided for University System of Maryland ventures.
|
Locked | Locked | Locked |
Investor details for Linshom
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Linshom
Investment portfolio details for Linshom
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Linshom
Detailed financials for Linshom
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Linshom Comparisons
Peer comparison for Linshom
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Linshom
Linshom operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Apieron, Eversens, Medipines, Deversify and Spirosure, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Functions as an asthma monitoring device for health management.
|
|
| Locked | Locked | Locked |
Developer of non-invasive diagnostic system to detect bio-markers
|
|
| Locked | Locked | Locked |
Non-invasive respiratory measurement devices are developed for gas exchange assessment.
|
|
| Locked | Locked | Locked |
Breath analyzers for acetone concentration in exhaled air are developed.
|
|
| Locked | Locked | Locked |
Non-invasive breathalyzers are developed for pulmonary disease monitoring.
|
Detailed competitors of Linshom
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Linshom
Complete news archive for Linshom
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Linshom
Linshom was founded in 2009 and raised its 1st funding round 8 years after it was founded.
Linshom is headquartered in Ellicott City, United States. It is registered at Ellicott City, Maryland, United States.
Richard Hughen is the current CEO of Linshom.
Linshom is a funded company, having raised a total of $3.35M across 9 funding rounds to date.
Developer of respiratory monitoring devices. The Linshom Respiratory Monitoring Device (LRMD) monitors and displays breaths per minute, seconds since last breath, relative tidal information, respiratory signals, and others. Consists of a disposable sensor, a control unit, and a monitor. Used non-invasively with an oxygen mask or nasal cannula setting.
Linshom has 6 investors. Key investors include NIH, HHS, TEDCO, Abell Foundation, and Lighthouse Labs.